Biological fluid levels of iron and iron-related proteins in Parkinson's disease: Review and meta-analysis
- PMID: 33098743
- DOI: 10.1111/ene.14607
Biological fluid levels of iron and iron-related proteins in Parkinson's disease: Review and meta-analysis
Abstract
Background and purpose: Several studies suggested a role or iron in the pathogenesis or Parkinson's disease (PD), and substantia nigra iron concentrarions have been found increased in PD. However, the results on cerebrospinal (CSF) and serum/plasma iron levels in PD patients have been controversial. The aim of this systematic review and meta-analysis was to establish the CSF and serum/plasma levels of iron and iron-related proteins (ferritin, transferrin, lactoferrin, haptoglobin, and hepcidine) levels, and the urine levels of iron, in patients with PD.
Methods: Four databases (PubMed, EMBASE, MedLine, and Web of Science - Core Collection) were reviewed for studies published from 1966 to October 5, 2020. References of interest were identified. A meta-analysis of eligible studies was performed according to the Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) and Meta-analysis of Observational Studies in Epidemiology (MOOSE) guidelines, using the R software package meta.
Results: A non-significant trend towards higher CSF iron levels and marginally significantly lower serum/plasma iron levels was observed in patients with PD compared with age- and sex-matched controls. CSF and serum/plasma ferritin and transferrin concentrations, and serum/plasma lactoferrin and haptoglobin concentrations did not differ significantly between PD patients and controls.
Conclusion: The findings of this study suggest an association between decreased serum/plasma iron levels and, possibly, higher CSF iron levels with risk of PD.
Keywords: Parkinson's disease; cerebrospinal fluid; ferritin; iron; serum/plasma; transferrin; urine.
© 2020 European Academy of Neurology.
References
REFERENCES
-
- Dias V, Junn E, Mouradian MM. The role of oxidative stress in Parkinson's disease. J Parkinsons Dis. 2013;3:461-491.
-
- Wei Z, Li X, Li X, Liu Q, Cheng Y. Oxidative stress in Parkinson's disease: a systematic review and meta-analysis. Front Mol Neurosci. 2018;11:236.
-
- Mezzaroba L, Alfieri DF, Colado Simão AN, Vissoci Reiche EM. The role of zinc, copper, manganese and iron in neurodegenerative diseases. Neurotoxicology. 2019;74:230-241.
-
- Wang JY, Zhuang QQ, Zhu LB, et al. Meta-analysis of brain iron levels of Parkinson’s disease patients determined by postmortem and MRI measurements. Sci Rep. 2016;6:36669.
-
- Genoud S, Senior AM, Hare DJ, Double KL. Meta-analysis of copper and iron in Parkinson’s disease brain and biofluids. Mov Disord. 2020;35:662-671.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
